Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response

Gastroenterology

Volumn 138, Issue 5, 2010, Pages

  Zerbini, Alessandro ^a   Pilli, Massimo ^a   Laccabue, Diletta ^a   Pelosi, Guido ^a   Molinari, Atim ^a   Negri, Elisa ^a   Cerioni, Simona ^a   Fagnoni, Francesco ^a   Soliani, Paolo ^b   Ferrari, Carlo ^a   Missale, Gabriele ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Hepatocellular Carcinoma; Natural Killer Cells; Radiofrequency Thermal Ablation

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY TEST; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT RESPONSE;

EID: 77951689275     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.12.051     Document Type: Article

References (44)

1. Lau W.Y., and Lai E.C. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249 (2009) 20-25
2. Lubienski A. Radiofrequency ablation in metastatic disease. Recent Results Cancer Res 165 (2005) 268-276
3. Gillams A.R., and Lees W.R. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19 (2009) 1206-1213
4. Le Veen R.F. Laser hypertermia and radiofrequency ablation of hepatic lesions. Semin Intervent Radiol 14 (1997) 313-324
5. Schueller G., Kettenbach J., Sedivy R., et al. Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo. Int J Oncol 24 (2004) 609-613
6. Schueller G., Kettenbach J., Sedivy R., et al. Expression of heat shock proteins in human hepatocellular carcinoma after radiofrequency ablation in an animal model. Oncol Rep 12 (2004) 495-499
7. Gravante G., Sconocchia G., Ong S.L., et al. Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver Int 29 (2009) 18-24
8. Vabulas R.M., Braedel S., Hilf N., et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. Biol Chem 277 (2002) 20847-20853
9. Ohashi K., Burkart V., Flohé S., et al. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164 (2000) 558-561
10. Dayanc B.E., Beachy S.H., Ostberg J.R., et al. Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia 24 (2008) 41-56
11. Den Brok M.H., Sutmuller R.P., van der Voort R., et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64 (2004) 4024-4029
12. Wissniowski T.T., Hansler J., Neureiter D., et al. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res 63 (2003) 6496-6500
13. Zerbini A., Pilli M., Penna A., et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 66 (2006) 1139-1146
14. den Brok M.H., Sutmuller R.P., Nierkens S., et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer 95 (2006) 896-905
15. Napoletano C., Taurino F., Biffoni M., et al. RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol 32 (2008) 481-490
16. Lanier L.L. NK-cell recognition. Annu Rev Immunol 23 (2005) 225-274
17. Moretta L., Bottino C., Pende D., et al. Surface NK receptors and their ligands on tumor cells. Semin Immunol 18 (2006) 151-158
18. Musolino A., Naldi N., Bortesi B., et al. Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer. J Clin Oncol 26 (2008) 1789-1796
19. Weng W.-K., and Levy R. Two immunoglobulin G fragment receptors polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 21 (2003) 3940-3947
20. Yamagiwa S., Kamimura H., and Ichida T. Natural killer cell receptors and their ligands in liver diseases. Med Mol Morphol 42 (2009) 1-8
21. Gao B., Jeong W.I., and Tian Z. Liver: an organ with predominant innate immunity. Hepatology 47 (2008) 729-736
22. Vermijlen D., Luo D., Froelich C.J., et al. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway. J Leukoc Biol 72 (2002) 668-676
23. Ishiyama K., Ohdan H., Ohira M., et al. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 43 (2006) 362-372
24. Kwon A.H., Matsui Y., and Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer 91 (2001) 771-778
25. Biron C.A., Nguyen K.B., Pien G.C., et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189-220
26. Young H.A., and Ortaldo J. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Cell Res 16 (2006) 20-24
27. Lotzová E. Definition and functions of natural killer cells. Nat Immun 12 (1993) 169-176
28. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK-cell responses to viral infection. J Immunol 169 (2002) 4279-4287
29. Carson W.E., Giri J.G., Lindemann M.J., et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180 (1994) 1395-1403
30. Gastpar R., Gross C., Rossbacher L., et al. The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK-cells. J Immunol 172 (2004) 972-980
31. Gastpar R., Gehrmann M., Bausero M.A., et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res 65 (2005) 5238-5247
32. Gleimer M., and Parham P. Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity 19 (2003) 469-477
33. Cerwenka A. New twist on the regulation of NKG2D ligand expression. J Exp Med 206 (2009) 265-268
34. Qiao Y., Liu B., and Li Z. Activation of NK-cells by extracellular heat shock protein 70 through induction of NKG2D ligands on dendritic cells. Cancer Immun 10 (2008) 8-12
35. Harima Y., Nagata K., Harima K., et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17 (2001) 97-105
36. Gross C., Schmidt-Wolf I.G., Nagaraj S., et al. Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress Chaperones 8 (2003) 348-360
37. Pilla L., Squarcina P., Coppa J., et al. Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. Cancer Res 65 (2005) 3942-3949
38. Farag S.S., Fehniger T.A., Becknell B., et al. New directions in natural killer cell-based immunotherapy of human cancer. Expert Opin Biol Ther 3 (2003) 237-250
39. Mazzolini G., Prieto J., and Melero I. Gene therapy of cancer with interleukin-12. Curr Pharm Des 9 (2003) 1981-1991
40. Kimura H., Sakai K., Arao T., et al. Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor. Cancer Sci 98 (2007) 1275-1280
41. Kurai J., Chikumi H., Hashimoto K., et al. Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines. Clin Cancer Res 13 (2007) 1552-1561
42. Armeanu S., Krusch M., Baltz K.M., et al. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Clin Cancer Res 14 (2008) 3520-3528
43. Hallett W.H., Ames E., Motarjemi M., et al. Sensitization of tumor cells to NK-cell-mediated killing by proteasome inhibition. J Immunol 180 (2008) 163-170
44. Zerbini A., Pilli M., Fagnoni F., et al. Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. J Immunother 31 (2008) 271-282